Apr 28, 2026
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $21.65 to $18.04.
The split itself did not change the total investment value.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A (SZSE:002393) operates in the Pharmaceuticals: major industry.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A company overviewTianjin Lisheng Pharmaceutical Co., Ltd. Class A's most recent stock split was on April 28, 2026. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A (SZSE:002393) has split its stock 2 times: a 7-for-5 split on May 28, 2024 and a 6-for-5 split on April 28, 2026.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between May 28, 2024 and April 28, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tianjin Lisheng Pharmaceutical Co., Ltd. Class A's 6-for-5 split on April 28, 2026, every 5 shares became 6 shares.
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on April 28, 2026, less than a year ago. Companies announce splits in advance, and any new SZSE:002393 split will appear on this page.
Already premium?